[go: up one dir, main page]

ITRM20020119A0 - Composizioni contenenti plgf ad uso farmaceutico e cosmetico. - Google Patents

Composizioni contenenti plgf ad uso farmaceutico e cosmetico.

Info

Publication number
ITRM20020119A0
ITRM20020119A0 IT2002RM000119A ITRM20020119A ITRM20020119A0 IT RM20020119 A0 ITRM20020119 A0 IT RM20020119A0 IT 2002RM000119 A IT2002RM000119 A IT 2002RM000119A IT RM20020119 A ITRM20020119 A IT RM20020119A IT RM20020119 A0 ITRM20020119 A0 IT RM20020119A0
Authority
IT
Italy
Prior art keywords
pharmaceutical
compositions containing
cosmetic use
plgf
containing plgf
Prior art date
Application number
IT2002RM000119A
Other languages
English (en)
Inventor
Giuseppe Salvia
Ettore Conti
Domenico Maglione
Marina Tucci
Mauro Battisti
Original Assignee
Geymonat Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM20020119(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat Spa filed Critical Geymonat Spa
Priority to IT2002RM000119A priority Critical patent/ITRM20020119A1/it
Publication of ITRM20020119A0 publication Critical patent/ITRM20020119A0/it
Priority to PL03371788A priority patent/PL371788A1/xx
Priority to CNB038051532A priority patent/CN100467058C/zh
Priority to PT37126521T priority patent/PT1482967E/pt
Priority to KR1020047013804A priority patent/KR100988656B1/ko
Priority to DK03712652.1T priority patent/DK1482967T3/da
Priority to HRP20040914 priority patent/HRP20040914A2/hr
Priority to AU2003217464A priority patent/AU2003217464B2/en
Priority to PCT/IT2003/000132 priority patent/WO2003074075A1/en
Priority to JP2003572591A priority patent/JP5010093B2/ja
Priority to HK05110410.6A priority patent/HK1078469B/xx
Priority to SI200332290T priority patent/SI1482967T1/sl
Priority to ES03712652T priority patent/ES2424827T3/es
Priority to EP03712652.1A priority patent/EP1482967B1/en
Priority to CA2477075A priority patent/CA2477075C/en
Priority to US10/507,272 priority patent/US7364722B2/en
Priority to BR0308040-4A priority patent/BR0308040A/pt
Priority to MXPA04008486A priority patent/MXPA04008486A/es
Priority to RU2004129586/15A priority patent/RU2292906C2/ru
Publication of ITRM20020119A1 publication Critical patent/ITRM20020119A1/it
Priority to ZA2004/07707A priority patent/ZA200407707B/en
Priority to JP2010007759A priority patent/JP5144690B2/ja
Priority to CY20131100692T priority patent/CY1114209T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT2002RM000119A 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico. ITRM20020119A1 (it)

Priority Applications (22)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
MXPA04008486A MXPA04008486A (es) 2002-03-05 2003-03-05 Composiciones farmaceuticas y cosmeticas que comprenden factor de crecimiento placentario tipo 1 (plgf-1).
RU2004129586/15A RU2292906C2 (ru) 2002-03-05 2003-03-05 Фармацевтические и косметические композиции, содержащие плацентарный фактор роста plgf-1
JP2003572591A JP5010093B2 (ja) 2002-03-05 2003-03-05 Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
ES03712652T ES2424827T3 (es) 2002-03-05 2003-03-05 Composiciones farmacéuticas y cosméticas que contienen PLGF-1
PT37126521T PT1482967E (pt) 2002-03-05 2003-03-05 Composições farmacêuticas e cosmética compreendendo plgf-1
KR1020047013804A KR100988656B1 (ko) 2002-03-05 2003-03-05 Ｐｌｇｆ-1을 포함하는 약학 조성물 및 미용 조성물
DK03712652.1T DK1482967T3 (da) 2002-03-05 2003-03-05 Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
HRP20040914 HRP20040914A2 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
AU2003217464A AU2003217464B2 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising PLGF-1
PCT/IT2003/000132 WO2003074075A1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
PL03371788A PL371788A1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
HK05110410.6A HK1078469B (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
SI200332290T SI1482967T1 (sl) 2002-03-05 2003-03-05 Farmacevtski in kozmetični sestavki, ki vsebujejo PLGF-1
CNB038051532A CN100467058C (zh) 2002-03-05 2003-03-05 含有plgf-1的药物和化妆品组合物
EP03712652.1A EP1482967B1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
CA2477075A CA2477075C (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
US10/507,272 US7364722B2 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1
BR0308040-4A BR0308040A (pt) 2002-03-05 2003-03-05 Composições farmacêuticas e cosméticas compreendendo plgf-1
ZA2004/07707A ZA200407707B (en) 2002-03-05 2004-09-23 Pharmaceutical and cosmetic compositions comprising plgf-1
JP2010007759A JP5144690B2 (ja) 2002-03-05 2010-01-18 Ｐｌｇｆ−１を含む医薬品及び化粧品組成物
CY20131100692T CY1114209T1 (el) 2002-03-05 2013-08-13 Φαρμακευτικες και καλλυντικες συνθεσεις που περιλαμβανουν plgf-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.

Publications (2)

Publication Number Publication Date
ITRM20020119A0 true ITRM20020119A0 (it) 2002-03-05
ITRM20020119A1 ITRM20020119A1 (it) 2003-09-05

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.

Country Status (20)

Country Link
US (1) US7364722B2 (it)
EP (1) EP1482967B1 (it)
JP (2) JP5010093B2 (it)
KR (1) KR100988656B1 (it)
CN (1) CN100467058C (it)
AU (1) AU2003217464B2 (it)
BR (1) BR0308040A (it)
CA (1) CA2477075C (it)
CY (1) CY1114209T1 (it)
DK (1) DK1482967T3 (it)
ES (1) ES2424827T3 (it)
HR (1) HRP20040914A2 (it)
IT (1) ITRM20020119A1 (it)
MX (1) MXPA04008486A (it)
PL (1) PL371788A1 (it)
PT (1) PT1482967E (it)
RU (1) RU2292906C2 (it)
SI (1) SI1482967T1 (it)
WO (1) WO2003074075A1 (it)
ZA (1) ZA200407707B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
AU2010210033A1 (en) * 2009-02-05 2011-08-04 Digna Biotech, S.L. Pharmaceutical compositions comprising TGF- beta1 inhibitor peptides
EP2456784B1 (en) 2009-07-24 2017-01-11 Advanced Accelerator Applications S.A. Compounds modulators of vegf activity and uses thereof
EP2948164B1 (en) * 2013-01-28 2019-04-10 Shire Human Genetic Therapies, Inc. Placenta growth factor in treating duchenne muscular dystrophy
US10052351B2 (en) 2014-01-17 2018-08-21 Mimedx Group, Inc. Method for inducing angiogenesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
IT1242149B (it) 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
US6211147B1 (en) * 1995-08-15 2001-04-03 Connetics Corporation Method of promoting angiogenesis using relaxin
RU2102091C1 (ru) * 1995-09-19 1998-01-20 Казанский медицинский университет Способ лечения системной склеродермии
WO1997048405A1 (fr) * 1996-06-21 1997-12-24 Jury Evgenievich Belyaev Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes
CA2315977A1 (en) * 1997-12-24 1999-07-08 Ludwig Institute For Cancer Research Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
EP1203074A4 (en) * 1999-06-29 2003-09-10 J Alexander Marchosky BONE FORMATION AND STRENGTHENING COMPOSITIONS AND METHOD
JP3877914B2 (ja) * 1999-09-07 2007-02-07 サンスター株式会社 皮膚化粧料
AU4643501A (en) * 2000-02-04 2001-08-14 Flanders Interuniversity Institute For Biotechnology (Vib) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2001316242A (ja) * 2000-03-02 2001-11-13 Noevir Co Ltd 皮膚外用剤
EP1267800A4 (en) * 2000-03-31 2004-08-25 Gen Hospital Corp METHOD FOR INFLUENCING HAIR GROWTH

Also Published As

Publication number Publication date
EP1482967B1 (en) 2013-05-15
CA2477075C (en) 2013-08-06
RU2292906C2 (ru) 2007-02-10
CN100467058C (zh) 2009-03-11
AU2003217464B2 (en) 2007-08-30
SI1482967T1 (sl) 2013-10-30
HK1078469A1 (zh) 2006-03-17
EP1482967A1 (en) 2004-12-08
RU2004129586A (ru) 2005-06-10
JP2005519101A (ja) 2005-06-30
PT1482967E (pt) 2013-08-27
KR20040111379A (ko) 2004-12-31
JP5010093B2 (ja) 2012-08-29
MXPA04008486A (es) 2005-04-19
PL371788A1 (en) 2005-06-27
US20050075288A1 (en) 2005-04-07
ITRM20020119A1 (it) 2003-09-05
CN1638793A (zh) 2005-07-13
JP5144690B2 (ja) 2013-02-13
ZA200407707B (en) 2005-07-27
CY1114209T1 (el) 2016-08-31
JP2010116405A (ja) 2010-05-27
HRP20040914A2 (en) 2004-12-31
AU2003217464A1 (en) 2003-09-16
BR0308040A (pt) 2004-12-14
US7364722B2 (en) 2008-04-29
KR100988656B1 (ko) 2010-10-18
ES2424827T3 (es) 2013-10-08
CA2477075A1 (en) 2003-09-12
DK1482967T3 (da) 2013-08-26
WO2003074075A1 (en) 2003-09-12
US20050239698A2 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
NO20033384D0 (no) Farmasöytisk formulering
ITTO20010008A0 (it) Formulazione farmaceutica
IL207028A0 (en) Pharmaceutical nati-tnf-alpha antibody formulation
PT1501534E (pt) Formulacoes farmaceuticas
DK1660104T3 (da) Farmaceutisk formulering indeholdende lanthanforbindelser
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
ATE317260T1 (de) Pharmazeutische formulierungen mit platinderivaten
BRPI0508259A (pt) derivado heterocìclico fundido, composição medicinal contendo o mesmo, e uso medicinal do mesmo
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
IL172937A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
NO20035627D0 (no) Farmasöytisk formulering
ITMI20020189A0 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
BR0208566B1 (pt) Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ITRM20020119A0 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
EP1682088A4 (en) ORAL MICROEMULSION COMPOSITION WITH BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBIN